We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Goodyear (GT) Q2 Earnings Beat, Revenues Miss Estimates
Read MoreHide Full Article
The Goodyear Tire & Rubber Company (GT - Free Report) is a leading manufacturer, retailer and distributor of tires and rubber-related chemicals for various applications.
Earnings
In the second-quarter, Goodyear reported adjusted earnings of 62 cents per share, beating the Zacks Consensus Estimate of 56 cents. The adjusted earnings in the year-ago quarter were 70 cents.
Revenues
Goodyear reported net revenue of $3.84 billion, higher than $3.70 billion recorded in the year-ago quarter. However, the figure missed the Zacks Consensus Estimate of $3.9 billion.
The Goodyear Tire & Rubber Company Price and EPS Surprise
Earnings estimate for Goodyear for the second quarter went down 5.1% over the past one month. In three out of the four trailing quarters, Goodyear reported positive earnings surprise while missing the estimate on one occasion. The company has delivered average positive earnings surprise of around 11.8%.
Key Stats/Developments to Note
Goodyear has reduced its 2018 segment operating income to the range of $1.45-$1.5 billion, considering a $70 million headwind due to softening market conditions in China, a $130 million increase in raw material costs and unfavorable foreign currency swing of $60 million.
Check back later for our full write up on Goodyear’s earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Goodyear (GT) Q2 Earnings Beat, Revenues Miss Estimates
The Goodyear Tire & Rubber Company (GT - Free Report) is a leading manufacturer, retailer and distributor of tires and rubber-related chemicals for various applications.
Earnings
In the second-quarter, Goodyear reported adjusted earnings of 62 cents per share, beating the Zacks Consensus Estimate of 56 cents. The adjusted earnings in the year-ago quarter were 70 cents.
Revenues
Goodyear reported net revenue of $3.84 billion, higher than $3.70 billion recorded in the year-ago quarter. However, the figure missed the Zacks Consensus Estimate of $3.9 billion.
The Goodyear Tire & Rubber Company Price and EPS Surprise
The Goodyear Tire & Rubber Company Price and EPS Surprise | The Goodyear Tire & Rubber Company Quote
Estimate Trend & Surprise History
Earnings estimate for Goodyear for the second quarter went down 5.1% over the past one month. In three out of the four trailing quarters, Goodyear reported positive earnings surprise while missing the estimate on one occasion. The company has delivered average positive earnings surprise of around 11.8%.
Key Stats/Developments to Note
Goodyear has reduced its 2018 segment operating income to the range of $1.45-$1.5 billion, considering a $70 million headwind due to softening market conditions in China, a $130 million increase in raw material costs and unfavorable foreign currency swing of $60 million.
Zacks Rank
Goodyear holds a Zacks Rank #3 (Hold), but that could change following its earnings report which has just released. Meanwhile, you can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Goodyear’s earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>